Regular Inhaled Corticosteroids Use May Protect Against Severe COVID-19 Outcome in COPD.

Marina Labor Brian K Kirui Fredrik Nyberg Lowie E G W Vanfleteren

Published in: International journal of chronic obstructive pulmonary disease (2023)

For COPD patients, ICS therapy offers some protection against progression to ICU admission and death among COVID-19 hospitalized patients. Our findings alleviate concerns about increased risks of COVID-19 by ICS treatment and provide evidence supporting the continuation of ICS therapy for COPD patients.

Keyphrases

coronavirus disease
end stage renal disease
sars cov
chronic obstructive pulmonary disease
ejection fraction
newly diagnosed
chronic kidney disease
peritoneal dialysis
stem cells
patient reported outcomes
mesenchymal stem cells
early onset
risk assessment
air pollution
mechanical ventilation
drug induced